3 completed, 1 recruiting. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 3, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow thymosin beta(4): new trials by email Literature Review of thymosin beta(4) trials Research Report on thymosin beta(4)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2 RGN-259, Placebo - Neurotrophic Keratopathy | Phase 3 | Recruiting | ReGenTree, LLC | 70 | 2023-04-11 | 2025-12-23 |
| Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3 RGN-259, Placebo - Dry Eye Syndromes, Dry Eye | Phase 3 | Completed | ReGenTree, LLC | 700 | 2019-05-24 | 2026-08-28 |
| Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2 RGN-259, Placebo - Dry Eye Syndrome | Phase 3 | Completed | ReGenTree, LLC | 601 | 2016-11-01 | 2026-10-21 |
| Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1 RGN-259, Placebo - Dry Eye Syndrome | Phase 2 / Phase 3 | Completed | ReGenTree, LLC | 317 | 2015-09-01 | 2019-10-17 |
ReGenTree, LLC (4)
United States (4) · Italy (1) · Poland (1) · Spain (1)